Antiplatelet Agents in Ischemic Heart Disease

2012 ◽  
pp. 495-518 ◽  
Author(s):  
Christopher H. May ◽  
A. Michael Lincoff
Keyword(s):  
Heart Disease ◽  
Ischemic Heart Disease ◽  
Antiplatelet Agents ◽  
Ischemic Heart

scholarly journals New Opportunities for Improving the Prognosis of Patients with Chronic Ischemic Heart Disease

2020 ◽  
Vol 15 (6) ◽  
pp. 873-880
Author(s):  
N. B. Perepech
Keyword(s):  
Heart Disease ◽  
Ischemic Heart Disease ◽  
Randomized Clinical Trials ◽  
Combined Therapy ◽  
Antiplatelet Agents ◽  
Ischemic Heart ◽  
Chronic Ischemic Heart Disease ◽  
Target Values ◽  
Artery Disease ◽  
European Society Of Cardiology

Resources and methods for improving the prognosis in patients with chronic ischemic heart disease (IHD) are presented in the review. Information on the classes of drugs that improve the prognosis, and target values of the main physiological parameters that should be monitored during the treatment of patients with chronic IHD are also presented. The main attention is paid to antiplatelet agents and anticoagulants. The results of the most significant randomized clinical trials of the efficacy and safety of drugs from these classes in the treatment of chronic IHD are discussed. The results of the COMPASS study, which obtained confirmation of the positive effect of combined therapy with rivaroxaban and acetylsalicylic acid on the prognosis of patients with chronic IHD or peripheral artery disease, are presented in detail. The safety aspects of this therapy are discussed. The position of rivaroxaban in the treatment of patients with chronic IHD with sinus rhythm is presented according to the Recommendations of the European Society of Cardiology for the diagnosis and treatment of chronic IHD (2019).

Oral antiplatelet agents in ischemic heart disease: a review of the latest clinical evidence

2011 ◽  
Vol 1 (9) ◽  
pp. 1315-1328
Author(s):  
Nadia Paarup Dridi ◽  
Lene Holmvang ◽  
Peter Clemmensen
Keyword(s):  
Heart Disease ◽  
Ischemic Heart Disease ◽  
Clinical Evidence ◽  
Antiplatelet Agents ◽  
Ischemic Heart
Sign in / Sign up

Export Citation Format

Share Document